Please wait a minute...
Reviews in Cardiovascular Medicine  2014, Vol. 15 Issue (2): 102-108     DOI: 10.3909/ricm0678
Review Previous articles | Next articles
Height and Heart Disease
Stuart W. Rosenbush, Jeremy M. Parker
Department of Internal Medicine, Section of Cardiology, Rush University Medical Center, Chicago, IL
Download:  PDF(221KB)  ( 184 )
Export:  BibTeX | EndNote (RIS)      
Abstract:
Height has a relationship with a number of medical conditions, including heart disease. Atrial fibrillation has been observed to be more common in taller individuals. Marfan syndrome, with its high prevalence of mitral valve disease and abnormalities of the aorta, is associated with increased height. Mitral valve prolapse in patients without Marfan syndrome may be more common in taller people. Conversely, congestive heart failure, coronary artery disease, and possibly aortic valve calcification are less prevalent with increasing height. The relationship between height and health will be of increasing importance as the population grows taller.
Key words:  Heart disease      Height      Atrial fibrillation      Marfan syndrome      Mitral valve prolapse      Congestive heart failure      Coronary artery disease     
Published:  30 June 2014     

Cite this article: 

Stuart W. Rosenbush, Jeremy M. Parker. Height and Heart Disease. Reviews in Cardiovascular Medicine, 2014, 15(2): 102-108.

URL: 

https://rcm.imrpress.com/EN/10.3909/ricm0678     OR     https://rcm.imrpress.com/EN/Y2014/V15/I2/102

[1] Meer Fakhry, Mandeep S. Sidhu, Sripal Bangalore, Roy O. Mathew. Accelerated and intensified calcific atherosclerosis and microvascular dysfunction in patients with chronic kidney disease[J]. Reviews in Cardiovascular Medicine, 2020, 21(2): 157-162.
[2] Anthony (Ming-yu) Chuang, Mau T Nguyen, Woon-Man Kung, Sam Lehman, Derek P Chew. High-sensitivity troponin in chronic kidney disease: Considerations in myocardial infarction and beyond[J]. Reviews in Cardiovascular Medicine, 2020, 21(2): 191-203.
[3] Zhi-Peng Song, Bo Yan. Potential roles of GATA binding protein 5 in cardiovascular diseases[J]. Reviews in Cardiovascular Medicine, 2020, 21(2): 253-261.
[4] Omar Kousa, Mohamed Mansour, Dana Awad, Amr Essa, Abdallah Qasim, Arindam Sharma, Mark Holmberg. Reversible bradycardia secondary to myxedema coma: case-report[J]. Reviews in Cardiovascular Medicine, 2020, 21(2): 297-301.
[5] Zhanru Qi, Hongyan Zheng, Zhonghai Wei, Qing Dai, Jun Xie, Lian Wang, Jingmei Zhang, Jie Song. Short-term and long-term outcomes of bailout versus planned coronary rotational atherectomy[J]. Reviews in Cardiovascular Medicine, 2020, 21(2): 309-314.
[6] Yuhong Liu, Zhihuan Zeng, Xing Yu, Tudi Li, Yusi Yao, Rong Chen, Jianyi Zheng. Impact of lipoprotein(a) on long-term outcomes after percutaneous coronary intervention in patients with reduced low-density lipoprotein cholesterol[J]. Reviews in Cardiovascular Medicine, 2020, 21(1): 147-153.
[7] M. Usmaan Bashir, Anjali Bhagra, Suraj Kapa, Christopher J. McLeod. Modulation of the autonomic nervous system through mind and body practices as a treatment for atrial fibrillation[J]. Reviews in Cardiovascular Medicine, 2019, 20(3): 129-137.
[8] Yun Tian, Pingji Deng, Bing Li, Jieqiong Wang, Ju Li, Yulan Huang, Yan Zheng. Treatment models of cardiac rehabilitation in patients with coronary heart disease and related factors affecting patient compliance[J]. Reviews in Cardiovascular Medicine, 2019, 20(1): 27-33.
[9] Christian O. Koelbl, Zoran S. Nedeljkovic, Alice K. Jacobs. Coronary Chronic Total Occlusion (CTO): A Review[J]. Reviews in Cardiovascular Medicine, 2018, 19(1): 33-39.
[10] Akanksha Agrawal, Deepanshu Jain, Eyob L. Feyssa, Aman M. Amanullah. Utility of Dobutamine Stress Echocardiography in Cardiac Risk Stratification of Patients Undergoing Orthotopic Liver Transplantation[J]. Reviews in Cardiovascular Medicine, 2017, 18(4): 146-154.
[11] Molly Orosey, Lohit Garg, Sahil Agrawal, Manyoo Agarwal, Jinu J. John, David E. Haines >, Wai Shun Wong. Atrioesophageal Fistula Following Radiofrequency Catheter Ablation of Atrial Fibrillation[J]. Reviews in Cardiovascular Medicine, 2017, 18(3): 115-122.
[12] Mehul A. Pragani, Karan P. Desai, Doralisa Morrone, Mandeep S. Sidhu, William E. Boden. The Role of Nitrates in the Management of Stable Ischemic Heart Disease: A Review of the Current Evidence and Guidelines[J]. Reviews in Cardiovascular Medicine, 2017, 18(1): 14-20.
[13] Sandeep K. Krishnan, Norman E. Lepor. Acute and Chronic Cardiovascular Effects of Hyperkalemia: New Insights Into Prevention and Clinical Management[J]. Reviews in Cardiovascular Medicine, 2016, 17(S1): 9-21.
[14] Matthew M. Schumaecker, Timothy R. Larsen, , David C. Sane. Cardiac Manifestations of Adrenal Insufficiency[J]. Reviews in Cardiovascular Medicine, 2016, 17(3-4): 131-136.
[15] Rohit Kumar, Aref M. Rahman, Brian L. Henry. A Review of the Clinical Subgroup Analyses From the RE-LY Trial[J]. Reviews in Cardiovascular Medicine, 2016, 17(1-2): 40-48.
No Suggested Reading articles found!